Literature DB >> 1652954

12S-hydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activation.

F Sekiya1, J Takagi, T Usui, K Kawajiri, Y Kobayashi, F Sato, Y Saito.   

Abstract

When platelets are activated by the recognition of exposed collagen fibers, they start synthesizing two major arachidonic acid metabolites, i.e. thromboxane A2 and 12S-hydroxyeicosatetraenoic acid (12-HETE) via cyclooxygenase and 12-lipoxygenase pathways, respectively. Although the physiological role of the former is well established, that of the latter has not been fully elucidated. Recently, we have revealed that 12-HETE interferes with collagen-induced platelet aggregation [Sekiya, F. et al. (1990) Biochim. Biophys. Acta 1044, 165-168]. In the present paper, we show that this substance enhances thrombin-induced aggregation of bovine platelets, in sharp contrast with the case of collagen. Additionally, 12-HETE is able to prevent the prostaglandin E1-induced elevation of platelet cAMP level and counteracts its inhibitory effect on platelet aggregations. With these observations, we propose a novel self-regulatory mechanism of platelets where 12-HETE plays a key role; it switches sensitivity of platelets from the primary agonist (collagen) to the secondary one (thrombin), and cancels the inhibitory effect of cAMP elevators.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652954     DOI: 10.1016/0006-291x(91)91376-n

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  A 12(S)-hydroxyeicosatetraenoic acid receptor interacts with steroid receptor coactivator-1.

Authors:  Y Kurahashi; H Herbertsson; M Söderström; M G Rosenfeld; S Hammarström
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  12-lipoxygenase: a potential target for novel anti-platelet therapeutics.

Authors:  Jennifer Yeung; Michael Holinstat
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2011-07-01

3.  An anti-platelet agent, OPC-29030, inhibits translocation of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid production in human platelets.

Authors:  Y Ozeki; Y Nagamura; H Ito; F Unemi; Y Kimura; T Igawa; J i Kambayashi; Y Takahashi; T Yoshimoto
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 4.  Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

Authors:  Melissa Gabbs; Shan Leng; Jessay G Devassy; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

5.  RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency.

Authors:  Gurpreet Kaur; Gauthami Jalagadugula; Guangfen Mao; A Koneti Rao
Journal:  Blood       Date:  2010-02-24       Impact factor: 22.113

6.  Increased platelet sensitivity to ADP in mice lacking platelet-type 12-lipoxygenase.

Authors:  E N Johnson; L F Brass; C D Funk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

7.  Hepoxilin A3 is the endogenous lipid mediator opposing hypotonic swelling of intact human platelets.

Authors:  A Margalit; Y Sofer; S Grossman; D Reynaud; C R Pace-Asciak; A A Livne
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

Review 8.  12-lipoxygenases and 12(S)-HETE: role in cancer metastasis.

Authors:  K V Honn; D G Tang; X Gao; I A Butovich; B Liu; J Timar; W Hagmann
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

9.  Effect of cytoplasmic pH on Ca(2+)-stimulated eicosanoid biosynthesis in human platelets.

Authors:  J S Edwards; J M Ritter
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

10.  Decreased arachidonic acid metabolism in human platelets by autologous neutrophils: possible role of cell adhesion.

Authors:  B Chabannes; P Molière; Y Pacheco; M Lagarde
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.